News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
234 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (21549)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
Business
INSYS Therapeutics Reports Third Quarter 2017 Results
Gross revenue was $48.9 million, resulting in net revenue of $30.7 million.
November 2, 2017
·
13 min read
INTEGRA Highlights Benefits of Low Retention Pipette Tips
The recently published Performance of Low Retention GripTips from INTEGRA demonstrates how these high quality consumables can improve pipetting performance for viscous and low surface tension liquids.
November 2, 2017
·
1 min read
Business
Bioblast Pharma Reports Third Quarter 2017 Financial Results
The company announced financial results for the third quarter ended September 30, 2017.
November 2, 2017
·
6 min read
EKF Procalcitonin Assay FDA Cleared and Validated for Beckman AU Chemistry Analyzers
EKF is pleased to confirm the immediate availability of a user defined application (UDA) for running this 10 minute test for bacterial infection and sepsis on these Beckman AU analyzers
November 2, 2017
·
3 min read
Business
Senomyx Reports Third Quarter 2017 Financial Results
“In the third quarter, we exceeded our quarterly financial guidance, made significant progress on the monetization of certain flavor assets through our strategic advisor and advanced our discussions towards establishing new collaborative research funding.”
November 2, 2017
·
13 min read
Business
Juniper Pharmaceuticals Reports Third Quarter 2017 Financial and Operating Results
Cash and cash equivalents were $22.1M at September 30, 2017, an increase of 3% from June 30, 2017.
November 2, 2017
·
14 min read
Business
Aratana Therapeutics Reports Third Quarter 2017 Financial Results
Aratana reported total net revenues of $6.2 M and a net loss of $8.9M or $0.21 diluted loss per share.
November 2, 2017
·
23 min read
Business
Mettler-Toledo International Reports Third Quarter 2017 Results
Sales in local currency increased 6% in the quarter compared with the prior year. Reported sales increased 7% as currency increased sales growth by 1% in the quarter.
November 2, 2017
·
42 min read
Business
Lantheus Holdings Reports 2017 Third Quarter Financial Results; Exceeds Third Quarter and Raises Full-Year 2017 Guidance
The Company’s worldwide revenues for the third quarter of 2017 totaled $79.9 million.
November 2, 2017
·
15 min read
Business
Intersect ENT Reports Third Quarter 2017 Results
Third quarter 2017 revenue was $22.3 million, a 21% increase over the third quarter 2016.
November 2, 2017
·
6 min read
Previous
17 of 24
Next